2016 ESMO General View

S. Senan discusses Which radiotherapy in concurrent chemoradiotherapy? during Which radiotherapy in concurrent chemoradiotherapy?

Copenhagen, - ESMO 2016 - S. Senan discusses Which radiotherapy in concurrent chemoradiotherapy? during Education Session: Optimal treatment of stage III NSCLC at the European Society of Medical Oncology's Asia (ESMO) meeting at the Bella Center here today, Friday October 7, 2016. The new meeting is the premier oncology event in Europe for basic, translational, clinical and population science. Photo by © MedMeetingImages/Todd Buchanan 2016

16ESMO01181S. Senan discusses Which radiotherapy in concurrent chemoradiotherapy during Which radiotherapy in concurrent chemoradiotherapy ESMO 2016